Naturally-occurring TGR5 agonists modulating glucagon-like peptide-1 biosynthesis and secretion

Peptides

Volumn 78, Issue , 2016, Pages 51-58

  Jafri, Laila ^a,d   Saleem, Samreen ^b,d   Calderwood, Danielle ^c   Gillespie, Anna ^c   Mirza, Bushra ^d   Green, Brian D ^c  

^a BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

^b PMAS ARID AGRICULTURE UNIVERSITY   (Pakistan)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d QUAID I AZAM UNIVERSITY   (Pakistan)

Author keywords

GIP; GLP 1; Incretin; Secretagogue; TGR5

Indexed keywords

ACETIC ACID ETHYL ESTER; ANTIDIABETIC AGENT; FURIN; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; INCRETIN; PROGLUCAGON; QUINOVIC ACID; QUINOVIC ACID 3BETA O BETA DEXTRO GLYCOPYRANOSIDE; QUINOVIC ACID 3BETA O BETA DEXTRO GLYCOPYRANOSYL (28-1) BETA DEXTRO GLUCOPYRANOSYL ESTER; UNCLASSIFIED DRUG; G PROTEIN COUPLED RECEPTOR; GLYCOSIDE; GPBAR1 PROTEIN, HUMAN; PLANT EXTRACT; SERINE PROTEINASE; TRITERPENE;

ANTIDIABETIC ACTIVITY; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; FAGONIA CRETICA; GENE EXPRESSION; HORMONE BLOOD LEVEL; HUMAN; MEDICINAL PLANT; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; AERIAL PLANT PART; AGONISTS; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; ENTEROENDOCRINE CELL; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; SECRETION (PROCESS); SIGNAL TRANSDUCTION; ZYGOPHYLLACEAE;

CELL LINE; ENTEROENDOCRINE CELLS; GASTRIC INHIBITORY POLYPEPTIDE; GENE EXPRESSION REGULATION; GLUCAGON-LIKE PEPTIDE 1; GLYCOSIDES; HUMANS; HYPOGLYCEMIC AGENTS; INCRETINS; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; PROGLUCAGON; PROPROTEIN CONVERTASES; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TRITERPENES; ZYGOPHYLLACEAE;

EID: 84958191684     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2016.01.015     Document Type: Article

References (38)

1. M. Ahmad, M.A. Khan, M. Arshad, and M. Zafar Ethnophytotherapical approaches for the treatment of diabetes by the local inhabitants of District Attock (Pakistan) Ethnobot. Leafl. 1 2004 7
2. C.J. Bailey, and C. Day Traditional plant medicines as treatments for diabetes Diabetes Care 12 1989 553 564
3. M. Barkatullah Ibrar, A. Rauf, T.B. Hadda, M.S. Mubarak, and S. Patel Quantitative ethnobotanical survey of medicinal flora thriving in Malakand Pass Hills, Khyber Pakhtunkhwa, Pakistan J. Ethanopharmacol. 169 2015 335 346
4. Q. Chen, and R.A. Reimer Dairy protein and leucine alter GLP-1 release and mRNA of genes involved in intestinal lipid metabolism in vitro Nutrition 25 2009 340 349
5. C. Clemmensen, S. Smajilovic, E.P. Smith, S.C. Woods, H. Bräuner-Osborne, R.J. Seeley, D.A. D'Alessio, and K.K. Ryan Oral l-arginine stimulates GLP-1 secretion to improve glucose tolerance in male mice Endocrinology 154 2013 3978 3983
6. K.A. Evans, B.W. Budzik, S.A. Ross, D.D. Wisnoski, J. Jin, R.A. Rivero, M. Vimal, G.R. Szewczyk, C. Jayawickreme, D.L. Moncol, T.J. Rimele, S.L. Armour, S.P. Weaver, R.J. Griffin, S.M. Tadepalli, M.R. Jeune, T.W. Shearer, Z.B. Chen, L. Chen, D.L. Anderson, J.D.M. Becherer De Los Frailes, and F.J. Colilla Discovery of 3-aryl-4-isoxazolecarboxamides as TGR5 receptor agonists J. Med. Chem. 52 2009 7962 7965
7. P.R. Flatt, C.J. Bailey, and B.D. Green Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes Front. Biosci. 13 2008 3648 3660
8. C. Genet, A. Strehle, C. Schmidt, G. Boudjelal, A. Lobstein, K. Schoonjans, M. Souchet, J. Auwerx, R. Saladin, and A. Wagner Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes J. Med. Chem. 53 2010 178 190
9. S.A. Gilani, R.A. Qureshi, S.J. Gilania, Indigenous uses of some important ethnobotanical herbs of Ayubia national park, Abbottabad, Pakistan (2007).
10. A.L. Gillespie, D. Calderwood, L. Hobson, and B.D. Green Whey proteins have beneficial effects on intestinal enteroendocrine cells stimulating cell growth and increasing the production and secretion of incretin hormones Food Chem. 189 2015 120 128
11. B.D. Green, and P.R. Flatt Incretin hormone mimetics and analogues in diabetes therapeutics Best Pract. Res. Clin. Endocrinol. Metabol. 21 2007 497 516
12. B.D. Green, P.R. Flatt, and C.J. Bailey Inhibition of dipeptidylpeptidase IV activity as a therapy of type 2 diabetes Exp. Opin. Emerg. Drugs 11 2006 525 539
13. J.R. Greenfield, I.S. Farooqi, J.M. Keogh, E. Henning, A.M. Habib, A. Blackwood, F. Reimann, J.J. Holst, and F.M. Gribble Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects Am. J. Clin. Nutr. 89 2009 106 113
14. K.V. Hand, L. Giblin, and B.D. Green Hormone profiling in a novel enteroendocrine cell line pGIP/neo: STC-1 Metabolism 61 2012 1683 1696
15. J.J. Holst, F.K. Knop, T. Vilsboll, T. Krarup, and S. Madsbad Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes Diabetes Care 34 2011 251 257
16. P. Hossain, B. Kawar, and M. Nahas Obesity and diabetes in the developing world - a growing challenge N. Engl. J. Med. 356 2007 213 215
17. K.L. Johnston, M.N. Clifford, and L.M. Morgan Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine Am. J. Clin. Nutr. 78 2003 728 733
18. V.P. Kamboj Herbal medicine Curr. Sci. 78 2000 35 39
19. S. Katsuma, A. Hirasawa, and G. Tsujimoto Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1 Biochem. Biophys. Res. Commun. 32 2005 386 390
20. J.A. Lovshin, and D.J. Drucker Incretin-based therapies for type 2 diabetes mellitus Nat. Rev. Endocrinol. 5 2009 262 269
21. T. Maruyama, Y. Miyamoto, T. Nakamura, Y. Tamai, H. Okada, E. Sugiyama, T. Nakamura, H. Itadani, and K. Tanaka Identification of membrane-type receptor for bile acids (M-BAR) Biochem. Biophys. Res. Commun. 298 2002 714 719
22. T. Maruyama, K. Tanaka, J. Suzuki, H. Miyoshi, N. Harada, T. Nakamura, Y. Miyamoto, A. Kanatani, and Y. Tamai Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice J. Endocrinol. 191 2006 197 205
23. M.A. Nauck, B. Baller, and J.J. Meier Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes Diabetes 53 2004 190 196
24. H.E. Parker, K.I. Wallis, C.W. Roux, K.Y. Wong, F. Reimann, and F.M. Gribble Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion Br. J. Pharmacol. 165 2012 414 423
25. T.W. Pols, J. Auwerx, and K. Schoonjans Targeting the TGR5-GLP-1 pathway to combat type 2 diabetes and non-alcoholic fatty liver disease Gastroenterol. Clin. Biol. 34 2010 270 273
26. E.P. Rafferty, A.R. Wylie, C.T. Elliott, O.P. Chevallier, D.J. Grieve, and B.D. Green In vitro and in vivo effects of natural putative secretagogues of glucagon-like peptide-1 (GLP-1) Sci. Pharm. 79 2011 615 621
27. E.P. Rafferty, A.R. Wylie, K.H. Hand, C.E. Elliott, D.J. Grieve, and B.D. Green Investigating the effects of physiological bile acids on GLP-1 secretion and glucose tolerance in normal and GLP-1R-/-mice Biol. Chem. 392 2011 539 546
28. E.B. Ramshur, T.R. Rull, and B.M. Wice Novel insulin/GIP co-producing cell lines provide unexpected insights into Gut K-cell function in vivo J. Cell Physiol. 192 2002 339 350
29. S. Saleem, L. Jafri, I. Haq, L.C. Chang, D. Calderwood, B.D. Green, and B. Mirza Plants Fagonia cretica and Hedera nepalensis contain natural compounds with potent dipeptidyl peptidase-4 (DPP-4) inhibitory activity J. Ethnophramacol. 156 2014 26 32
30. D.A. Sandoval, and D.A. D'Alessio Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease Physiol. Rev. 95 2015 513 548
31. H. Sato, C. Genet, A. Strehle, C. Thomas, A. Lobstein, A. Wagner, C. Mioskowski, J. Auwerx, and R. Saladin Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea Biochem. Biophys. Res. Commun. 362 2007 793 798
32. P. Schwientek, R. Szczepanowski, C. Ruckert, J. Kalinowski, A. Klein, K. Selber, U.F. Wehmeier, J. Stoye, and A. Puhler The complete genome sequence of the acarbose producer Actinoplanes sp. SE50/110 BMC Genom. 13 2012 112
33. M.B. Toft-Nielsen, M.B. Damholt, S. Madsbad, L.M. Hilsted, T.E. Hughes, B.K. Michelsen, and J.J. Holst Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients J. Clin. Endocrinol. Metab. 86 2001 3717 3723
34. C. Verdich, S. Toubro, B. Buermann, M.J. Lysgard, H.J. Juul, and A. Astrup The role of postprandial releases of insulin and incretin hormones in mean-induced satiety-effect of obesity and weight reduction Int. J. Obes. Relat. Metab. Disord. 25 2001 1206 1214
35. T. Vilsboll, F.K. Knop, T. Krarup, A. Johansen, S. Madsbad, S. Larsen, T. Hansen, O. Pedersen, and J.J. Holst The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype J. Clin. Endocrinol. Metab. 88 2003 4897 4903
36. M. Watanabe, S.M. Houten, i C. Matak, M.A. Christoffolete, B.W. Kim, H. Sato, N. Messaddeq, J.W. Harney, O. Ezaki, T. Kodama, K. Schoonjans, A.C. Bianco, and J. Auwerx Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation Nature 439 2006 484 489
37. N.M. Whalley, L.E. Pritchard, D.M. Smith, and A. White Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells J. Endocrinol. 211 2011 99 106
38. T. Yonezawa, R. Kurata, K. Yoshida, M.A. Murayama, X. Cui, and A. Hasegawa Free fatty acids-sensing G protein-coupled receptors in drug targeting and therapeutics Curr. Med. Chem. 20 2013 3855 3871